+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action



Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action



Clinical and Investigative Medicine. Medecine Clinique et Experimentale 3(1-2): 41-47




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 044859609

Download citation: RISBibTeXText

PMID: 7009003


Related references

Acute treatment with verapamil of paroxysmal supraventricular tachycardia and atrial flutter in paediatric age. Giornale Italiano di Cardiologia 9(4): 368-373, 1979

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. Annals of Internal Medicine 94(1): 1-6, 1981

Azimilide for the treatment of atrial fibrillation, atrial flutter, and paroxysmal supraventricular tachycardia: results of a randomized trial and insights on the concordance of symptoms and recurrent arrhythmias. Journal of Cardiovascular Electrophysiology 19(2): 172-177, 2008

Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group. Journal of the American College of Cardiology 17(2): 297-303, 1991

Intravenous verapamil in the treatment of paroxysmal supraventricular tachycardia in children. Australian Paediatric Journal 19(1): 40-44, 1983

Intravenous verapamil in the prehospital treatment of paroxysmal supraventricular tachycardia. Annals of Emergency Medicine 19(3): 291-294, 1990

Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. American Journal of Cardiology 63(11): 693-696, 1989

Mechanism of termination of reentrant atrioventricular nodal paroxysmal supraventricular tachycardia by intravenous verapamil--an intracardiac electrophysiologic study. Indian Heart Journal 35(1): 8, 1983

Sustained atrial fibrillation after conversion of paroxysmal reciprocating junctional tachycardia by intravenous verapamil. American Journal of Cardiology 62(10 Pt 1): 835-837, 1988

Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled study. American Heart Journal 129(4): 739-748, 1995

Can common-type atrial flutter be a sign of an arrhythmogenic substrate in paroxysmal atrial fibrillation? Clinical and ablative consequences in patients with coexistent paroxysmal atrial fibrillation/atrial flutter. Circulation 116(24): 2786-2792, 2007

Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation. American Journal of Cardiology 65(9): 628-632, 1990

Tolerance and efficacy of flecainide vs propafenone for the long-term management of paroxysmal supraventricular tachycardia or atrial fibrillation. Circulation 88(4 Part 2): I446, 1993

On a case of supraventricular paroxysmal tachycardia resistant to treatment. Transitory conversion into atrial fibrillation by rapid atrial electric stimulation. Medicina Interna 24(11): 1393-1400, 1972

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group. American Journal of Cardiology 63(15): 1046-1051, 1989